- Sarepta Says Another Patient Died After Receiving Gene Therapy Bloomberg
- Patient dies in Sarepta gene therapy trial, adding to safety concerns STAT
- Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting The Boston Globe
- Third death from a Sarepta gene therapy BioCentury
- Sarepta Therapeutics Stock Is Surging After The Bell: What’s Going On? Yahoo Finance
Source link
